This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tohoku University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Hiroki Kato: Innovator in Hematopoiesis Research
Introduction
Hiroki Kato is a prominent inventor based in Miyagi, Japan. He has made significant contributions to the field of hematopoiesis, particularly in developing treatments for anemia. His innovative work has the potential to improve the quality of life for many individuals suffering from this condition.
Latest Patents
Hiroki Kato holds a patent for a hematopoiesis-enhancing agent. The purpose of this invention is to provide a novel hematopoiesis-promoting agent and a medicament that comprises this agent as an active ingredient for preventing or treating anemia, especially refractory anemia. The invention specifically includes an S-adenosylmethionine synthase inhibitor, which plays a crucial role in promoting hematopoiesis.
Career Highlights
Kato is affiliated with Tohoku University, where he conducts his research and development activities. His work at the university has allowed him to explore innovative solutions to medical challenges, particularly in the area of blood disorders.
Collaborations
Hiroki Kato has collaborated with notable colleagues, including Kazuhiko Igarashi and Yusho Ishii. These partnerships have fostered a collaborative environment that enhances the research and development of new medical treatments.
Conclusion
Hiroki Kato's contributions to hematopoiesis research exemplify the impact of innovation in medicine. His patent for a hematopoiesis-enhancing agent represents a significant advancement in the treatment of anemia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile